Penilaian Aktivitas Penyakit Lupus Eritematosus Sistemik dengan Skor SLEDAI di Departemen Ilmu Kesehatan Anak RSCM
Sari
Latar belakang. Keberhasilan tata laksana penyakit lupus eritematosus sistemik (LES) memerlukan
pemantauan tertentu. Skor systemic lupus erythematosus disease activity index (SLEDAI) adalah alat ukur
yang dapat digunakan untuk tata laksana sehari-hari. Saat ini belum ada data mengenai pemantauan aktivitas
penyakit LES anak menggunakan skor SLEDAI dengan rentang waktu tertentu.
Tujuan. Memantau aktivitas penyakit LES anak dengan skor SLEDAI setiap 3 bulan selama satu tahun
pengamatan.
Metode. Studi deskriptif retrospektif menggunakan data rekam medik dari 01 Juli 2005 sampai dengan
31 Juli 2013.
Hasil. Tigapuluh rekam medik memenuhi kriteria penelitian. Manifestasi awal tersering berdasarkan skor
SLEDAI adalah artritis, rash, demam, peningkatan dsDNA, dan komplemen darah rendah. Perubahan skor
SLEDAI terutama terlihat pada pengamatan antara bulan ke-0 dengan bulan ke-3. Pada awal pengamatan,
mayoritas pasien termasuk high activity, tetapi pada akhir pengamatan menjadi no activity.
Kesimpulan. Penilaian skor SLEDAI setiap 3 bulan dapat digunakan untuk memantau aktivitas penyakit
LES anak.
Kata Kunci
Teks Lengkap:
PDFReferensi
Akib AAP, Soepriadi M, Setiabudiawan B. Lupus
eritematosussistemik. Dalam: Akib AAP, Munasir Z,
Kurniati N, penyunting. Buku ajar alergi-imunologi
anak. Edisi kedua. Jakarta: Badan Penerbit IDAI; 2008.
h.346-73.
Gitelman MSK, Miller ML. Systemic lupus erythematosus.
Dalam: Behrman RE, Kliegman RM, Jenson
HB, penyunting. Nelson textbook of pediatrics. Edisi
ke–17. Philadelphia: Saunders; 2004.h.809-13.
Lam GKW dan Petri M. Assessment of systemic lupus
erythematosus. Clin Exp Rheumatol 2005;23Supl39:
-32.
Lehman TJA. Systemic lupus erythematosus in
childhood and adolescence. Dalam: Wallace DJ,
Hahn BH, penyunting. Dubois’ lupus erythematosus.
Edisi ke-7. Philadelphia: Lippincott Williams and
Wilkins;2007.h.848-66.
Alatas H. Nefritis lupus. Dalam: Alatas H, Tambunan T,
Trihono PP, Pardede SO, penyunting. Buku ajar nefrologi
anak. Jakarta: Balai Penerbit FKUI;2004.h.366-80.
Petty RE, Laxer RM. Systemic lupus erythematosus.
Dalam: Cassidy JT, Petty RE, penyunting. Textbook of
pediatric rheumatology. Edisi ke-5. Philadelphia: Elsevier
Saunders; 2005.h.342-91.
Sudewi NP, Kurniati N, Suyoko EMD, Munasir Z, Akib
AAP. Karakteristik klinis lupus eritematosus sistemik
pada anak. Sari Pediatri 2009;11:108-12.
Gladdman DD, Goldsmith CH, Urowitz MB, Bacon P,
Bombardier C, Isenberg D, dkk. Sensitivity to change of
systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994;21:1468-
Brunner HI, Silverman ED, Bombardier C, Feldman
BM. European consensus lupus activity measurement
is sensitive to change in disease activity in childhoodawitan
systemic lupus erythematosus.Arthritis Rheum
;49:335-341.
Yee CS, Isenberg DA, Prabu A, Sokoll K, The LS,
Rahman A, dkk. BILAG-2004 index captures systemic
lupus erythematosus disease activity better than
SLEDAI-2000. Ann Rheum Dis 2008;67:873-6.
Brunner HI, Feldman BM, Bombardier C, Silverman ED.
Sensitivity of the systemic lupus erythematosus disease
activity index, British isles lupus assessment group index,
and systemic lupus activity measure in the evaluation
of clinical change in childhood onset systemic lupus
erythematosus. Arthritis Rheum1999;42:1354-60.
Khanna S, Pal H, Pandey RM, Handa R. The relationship
between disease activity and quality of life in systemic
lupus erythematosus. J Rheumatol 2004;43:1536-40.
Mosca M, Bombardieri S. Assessing remission in systemic
lupus erythematosus. Clin Exp Rheumatol 2006;24Supl
:S100-S104.
Ibanez D, Gladman DD, Touma Z, Nikpour M,
Urowitz MB. Optimal frequency of visits for patients
with systemic lupus erythematosus to measure disease
activity over time. J Rheumatol 2011;38:60-3.
Gomez LAR, Uribe OU, Uribe OO, Romero HG,
Cardiel MH, Wojdyla D, dkk. Childhood systemic lupus
erythematosus in latinamerica: the gladel experience in
children. Lupus 2008;17:596-604.
Gulay CB, Dans LF. Clinical presentations and outcomes
of filipino juvenile systemic lupus erythematosus. Ped
Rheum 2011;9:1-7
Muzaffer MA dan Al-Mayouf SM. Clinical and laboratory
variables of childhood systemic lupus erythematosus
in western province of Saudi Arabia. Rheumatol Int
;31:23-26.
Bakr A. Epidemiology treatment and outcome of
childhood systemic lupus erythematosus in Egypt.
Pediatr Nephrol 2005;20:1081-6.
Gonzalez B, Hernandez P, Olguin H, Miranda M, Lira
L, Toso M, dkk. Changes in the survival of patients with
systemic lupus erythematosus in childhood: 30 years
experience in chile. Lupus 2005;14:918-23.
FitzGerald JD dan Grossman JM. Validity and reliability
of retrospective assessment of disease activity and flare
in observational cohorts of lupus patients. Lupus
;8:638-44.
Dung NTN, Loan HT, Nielsen S, Zak M, Petersen FK.
Juvenile systemic lupus erythematosus awitan patterns in
vietnamese children: a descriptive study of 45 children.
Pediatr Rheum 2012;10:38-44.
Hiraki LT, Benseler M, Tyrrell PN, Hebert D,
Harvey E, Silverman ED. Clinical and laboratory
characteristics and long-term outcome of pediatric
systemic lupus erythematosus: a longitudinal study. J
Pediatr 2008;152:550-6
Benseler SM dan Silverman ED. Systemis lupus
erythematosus. Pediatr Clin Am 2005;52:443-67.
Gottlieb BS, Ilowite NT. Systemic lupus erythematosus
in children and adolescents. Pediatr in Rev 2006;27:323-
Barr SG, Zonana-Nacach A, Magder LS, Petri M. Patterns
of disease activity in systemic lupus erythematosus.
Arthritis Rheum 1999;42:2682-8.
Brunner HI, Gladman DD, Ibanez D, Urowitz MD,
Silverman ED. Difference in disease features between
childhood-onset and adult-onset systemic lupus
erythematosus. Arthritis Rheum 2008;58:556-62.
DOI: http://dx.doi.org/10.14238/sp16.4.2014.292-8
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc-sa4.footer##
Email: editorial [at] saripediatri.org
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.